| Specialty | GLP-1 / weight loss (membership plus medication) |
|---|---|
| Medications | Compounded semaglutide and tirzepatide priced by dose; brand GLP-1s through insurance or self-pay |
| Price | Health membership $79 a month, or $49 a month on a 12-month plan, plus medication priced by dose: compounded semaglutide from $60 and tirzepatide from $90 at the starting dose (joinmochi.com, read November 20, 2026). |
| Read status | Re-read November 20, 2026 |
| Score | 68/100 · v4.1 score from pages read November 20, 2026 |
| Website | joinmochi.com |
How Mochi Health scored, category by category
Each line below comes from Mochi Health’s own pages, read November 20, 2026, scored against the published v4.1 scoring guide. Total: 68 of 100, rank 5 of 10.
| Category | Points | What we found |
|---|---|---|
| Pricing transparency | 14 of 20 | Membership and starting-dose medication prices printed (4 of 8); billing terms stated (4); priced “to your dose” with only the starting dose shown (2 of 4); no conflicting figures (4). |
| Total annual cost | 10 of 20 | $1,308 at the starting dose ($60 semaglutide plus a $49 membership on a 12-month plan, for 12 months). The maintenance-dose price is not printed, so this category is capped at 10. |
| Clinical oversight | 12 of 15 | Video visit with a board-certified provider (5); follow-up visits and dose adjustments (5); prescribers belong to independently owned practices that are not named (2 of 5). |
| Pharmacy transparency | 2 of 15 | Compounded drugs come from “licensed partner pharmacies”; none is named and no license type is stated. |
| Support | 10 of 10 | 24/7 care team and phone line (5); nutrition visits included (5). |
| Regulatory disclosure | 10 of 10 | Says compounded medications “are not approved or evaluated by the FDA” (6); no FDA warning letter found (4). |
| Accessibility | 10 of 10 | Compounded medication “ships to all 50 states and Washington, DC” (4); FSA/HSA and insurance (3); cancel anytime from the account (3). |
| Total | 68 of 100 | Rank 5 of the 10 GLP-1 programs scored on November 20, 2026 (ties ordered by annual-cost points). |
What we verified on November 20, 2026
We read Mochi’s FAQ and weight-loss page on November 20, 2026. In October its compounded prices were not printed; they now are, as starting-dose figures. The FAQ also lists a compounded orforglipron from $31; orforglipron is the ingredient in FDA-approved Foundayo, and we take no view here on whether a compounded version is lawful. We did not enroll, so we could not see intake-only fees, the pharmacy that fills each order or any price that appears only after checkout.
Five checks before you enroll
- The prescriber. Look up the clinician’s name in the NPPES NPI Registry and on your state medical or nursing board site.
- The pharmacy. Ask which pharmacy fills the prescription and check its license with your state board of pharmacy (FDA’s BeSafeRx links to each board).
- The 12-month total. Add the program or membership fee, the medication at your expected maintenance dose and shipping, then multiply by 12 (by 13 for 28-day cycles).
- The exit terms. Read the cancellation and refund rules before the first charge.
- The drug itself. Ask whether you will get an FDA-approved brand product or a compounded preparation. Compounded semaglutide and tirzepatide are not FDA-approved and are not generics.
How Mochi Health compares with NexLife
NexLife, the highest-scoring GLP-1 program at 86/100 on the v4.1 methodology, publishes compounded semaglutide at $95 a month and tirzepatide at $115 a month on 12-month plans ($109 and $129 month to month), the same price at every dose with no membership. It lost points for an open FDA warning letter (730096, June 8, 2026) and for conflicting price, state and pharmacy statements on its own pages. Price check: month to month, Mondae lists $126 for tirzepatide and $87 for semaglutide, and Eden Health $99 for semaglutide (read November 20, 2026). Our NexLife vs Mochi Health comparison sets the two side by side.
Related reading
Sources
- Mochi Health FAQ, read November 20, 2026.
- Mochi Health weight-loss page, read November 20, 2026.
- Our v4.1 scoring guide, published November 20, 2026.
GLP-1 program scores use the v4.1 methodology and pages read November 20, 2026; peptide and hormone clinics keep their May 2026 profiles and are not part of that ranking.